Evid Invest
Who owns EWTXWhat EWTX owns — n/a

Who owns Edgewise Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of EWTX from SEC Form 13F filings across 254 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 254 institutions disclosed 125.1M shares of Edgewise Therapeutics, Inc. worth $5.08B — about 114.9% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

254

13F holders

$5.08B

value, 2026 filers

114.9%

of shares outstanding (125.1M sh)

49

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of EWTX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1ORBIMED ADVISORS LLC15.5M$630.1M11.5%14.3%0.0%
2Paradigm Biocapital Advisors LP10.8M$437.6M8.7%9.9%+5.5%
3RA CAPITAL MANAGEMENT, L.P.8.4M$340.7M3.4%7.7%0.0%
4Janus Henderson Group Ltd.NEW7.3M$296.3M0.1%6.7%new
5BlackRock, Inc.7.3M$295.3M0.0%6.7%+10.1%
6NOVO HOLDINGS A/S5.3M$217.2M14.6%4.9%0.0%
7Driehaus Capital Management LLC4.4M$178.7M1.2%4%-6.9%
8PERCEPTIVE ADVISORS LLC4.1M$168.0M2.9%3.8%-5.4%
9VANGUARD CAPITAL MANAGEMENT LLC3.9M$159.6M0.0%3.6%+1.8%
10BAKER BROS. ADVISORS LP3.7M$150.3M0.7%3.4%0.0%
11Siren, L.L.C.2.8M$113.8M2.7%2.6%-11.9%
12BANK OF AMERICA CORP /DE/2.6M$105.3M0.0%2.4%+66.5%
13CITADEL ADVISORS LLC2.6M$104.4M0.0%2.4%+447.3%
14First Light Asset Management, LLC2.5M$100.8M6.0%2.3%+126.7%
15Integral Health Asset Management, LLC2.4M$97.4M5.9%2.2%+20.0%
16GEODE CAPITAL MANAGEMENT, LLC2.3M$92.7M0.0%2.1%+5.0%
17BRAIDWELL LP2.1M$84.0M3.5%1.9%+3.6%
18STATE STREET CORP1.9M$77.1M0.0%1.7%+3.9%
19Cormorant Asset Management, LP1.9M$75.5M5.1%1.7%-25.9%
20MORGAN STANLEY1.7M$70.7M0.0%1.6%-10.6%
21ALLIANCEBERNSTEIN L.P.1.7M$70.3M0.0%1.6%-18.2%
22MPM BIOIMPACT LLC1.6M$64.0M4.7%1.4%-2.8%
23MARSHALL WACE, LLP1.3M$51.0M0.0%1.2%+20477.5%
24Deep Track Capital, LPNEW1.1M$46.6M0.8%1.1%new
25AMERICAN CENTURY COMPANIES INC1.1M$45.8M0.0%1%+0.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.